Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Pro
Klonalität:
Polyclonal
Reinheit:
Antigen affinity chromatography
Formulierung:
Purified
Antibody Type:
Polyclonal Antibody
Application Verdünnung:
ELISA detection: 0.01-0.1 ,µg/ml
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
